Esperion Therapeutics, Inc. (ESPR)

Esperion Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for ESPR stock have an average target of 8.83, with a low estimate of 2.50 and a high estimate of 16. The average target predicts an increase of 269.46% from the current stock price of 2.39.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.50	$8.83	$8.00	$16
Change	+4.60%	+269.46%	+234.73%	+569.46%

Analyst Ratings

The average analyst rating for ESPR stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '24	Mar '24	Apr '24	May '24	Jun '24	Jul '24
Strong Buy	3	3	3	3	2	2
Buy	1	0	0	0	0	0
Hold	3	1	1	1	1	1
Sell	0	0	0	0	1	1
Strong Sell	0	0	0	0	0	0
Total	7	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Serge Belanger Needham	Needham	Strong Buy Reiterates $8	Strong Buy	Reiterates	$8	+234.73%	Jun 28, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $16	Strong Buy	Reiterates	$16	+569.46%	Jun 28, 2024
Jason Zemansky B of A Securities	B of A Securities	Hold → Sell Downgrades $2.9 → $2.5	Hold → Sell	Downgrades	$2.9 → $2.5	+4.60%	Jun 20, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $16	Strong Buy	Reiterates	$16	+569.46%	May 22, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $16	Strong Buy	Reiterates	$16	+569.46%	May 21, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

330.88M

Increased by 184.42%

from 116.33M

Revenue Next Year

425.78M

Increased by 28.68%

from 330.88M

EPS This Year

-0.04

from -2.03

EPS Next Year

0.01

from -0.04

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	148.36M	227.55M	78.45M	75.48M	116.33M	330.88M	425.78M	742.92M	886.07M	1.37B
Revenue Growth	-	53.37%	-65.52%	-3.79%	54.14%	184.42%	28.68%	74.48%	19.27%	54.50%
EPS	-3.59	-5.23	-9.31	-3.52	-2.03	-0.04	0.01	1.49	1.94	3.56
EPS Growth	-	-	-	-	-	-	-	14,500.00%	30.48%	83.20%
Forward PE	-	-	-	-	-	-	234.31	1.60	1.23	0.67
No. Analysts	-	-	-	-	-	10	8	5	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	403.7M	698.0M	1.0B	1.3B	2.2B
Avg	330.9M	425.8M	742.9M	886.1M	1.4B
Low	286.9M	288.8M	487.8M	491.4M	578.6M

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	247.0%	111.0%	136.5%	74.7%	148.2%
Avg	184.4%	28.7%	74.5%	19.3%	54.5%
Low	146.7%	-12.7%	14.6%	-33.9%	-34.7%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	0.18	0.66	2.30	3.22	6.27
Avg	-0.04	0.01	1.49	1.94	3.56
Low	-0.25	-0.31	0.72	0.73	0.99

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	-	-	22,444.1%	116.5%	222.6%
Avg	-	-	14,500.0%	30.5%	83.2%
Low	-	-	6,913.7%	-51.3%	-49.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.